258 related articles for article (PubMed ID: 1283251)
1. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
3. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
[TBL] [Abstract][Full Text] [Related]
4. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
5. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
Merz H; Fliedner A; Orscheschek K; Binder T; Sebald W; Müller-Hermelink HK; Feller AC
Am J Pathol; 1991 Nov; 139(5):1173-80. PubMed ID: 1951632
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
10. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
12. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome.
De Vita S; Dolcetti R; Ferraccioli G; Pivetta B; De Re V; Gloghini A; D'Agosto A; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1995 Sep; 22(9):1674-80. PubMed ID: 8523344
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors.
Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY
Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.
Foss HD; Hummel M; Gottstein S; Ziemann K; Falini B; Herbst H; Stein H
Am J Pathol; 1995 Jan; 146(1):33-9. PubMed ID: 7856736
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
[TBL] [Abstract][Full Text] [Related]
17. IL-2 mRNA expression in Tac-positive malignant lymphomas.
Peuchmaur M; Emilie D; Crevon MC; Solal-Celigny P; Maillot MC; Lemaigre G; Galanaud P
Am J Pathol; 1990 Feb; 136(2):383-90. PubMed ID: 2305833
[TBL] [Abstract][Full Text] [Related]
18. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
19. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
20. [Cytokines and malignant lymphomas].
Feller AC; Merz H
Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]